These compounds may interact with:
ALK tyrosine kinase receptor
Potentially involved in: lung cancer; cancer; neuroblastoma; melanoma; kidney cancer; carcinoma; skin cancer; allergic hypersensitivity disease; adenocarcinoma in situ; allergic rhinitis; alcoholic intoxication, chronic; brain neoplasms; non-small cell lung carcinoma; renal cell carcinoma; neoplastic cell transformation; mental depression; depressive disorder; granuloma, plasma cell; neoplasm metastasis; neoplasm recurrence, local
Disease data sourced from Pharos.